Atea Pharmaceuticals, Inc. (AVIR)

CIK 1593899 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Atea Pharmaceuticals, Inc..

Recent SEC filings

FiledFormAccession number
Aug 12, 202610-Q0001193125-26-347021
Aug 12, 20268-K0001193125-26-346888
Jun 23, 202640001193125-26-279717
Jun 23, 202640001193125-26-279720
Jun 23, 202640001193125-26-279723
Jun 23, 202640001193125-26-279726
Jun 23, 202640001193125-26-279728
Jun 23, 202640001193125-26-279718
Jun 23, 202640001193125-26-279719
Jun 23, 202640001193125-26-279721
Jun 22, 20268-K0001193125-26-277639
May 21, 20264/A0001193125-26-235039
May 20, 202640001193125-26-232612
May 12, 20268-K0001193125-26-219507
May 12, 202610-Q0001193125-26-219678
May 6, 2026SCHEDULE 13G/A0000315066-26-001112
Apr 27, 2026DEF 14A0001193125-26-182293
Apr 27, 2026DEFA14A0001193125-26-182340
Mar 26, 2026SCHEDULE 13G/A0000102909-26-000786
Mar 13, 202640001193125-26-106547
Mar 5, 20268-K0001193125-26-093961
Mar 5, 202610-K0001193125-26-094159
Feb 9, 2026SCHEDULE 13G0001373604-26-000010
Feb 3, 202640001193125-26-036272
Feb 3, 202640001193125-26-036268